Cargando…

On the Mechanism of Cytoprotection by Ferrostatin-1 and Liproxstatin-1 and the Role of Lipid Peroxidation in Ferroptotic Cell Death

[Image: see text] Ferroptosis is a form of regulated necrosis associated with the iron-dependent accumulation of lipid hydroperoxides that may play a key role in the pathogenesis of degenerative diseases in which lipid peroxidation has been implicated. High-throughput screening efforts have identifi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zilka, Omkar, Shah, Ron, Li, Bo, Friedmann Angeli, José Pedro, Griesser, Markus, Conrad, Marcus, Pratt, Derek A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2017
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5364454/
https://www.ncbi.nlm.nih.gov/pubmed/28386601
http://dx.doi.org/10.1021/acscentsci.7b00028
_version_ 1782517322636853248
author Zilka, Omkar
Shah, Ron
Li, Bo
Friedmann Angeli, José Pedro
Griesser, Markus
Conrad, Marcus
Pratt, Derek A.
author_facet Zilka, Omkar
Shah, Ron
Li, Bo
Friedmann Angeli, José Pedro
Griesser, Markus
Conrad, Marcus
Pratt, Derek A.
author_sort Zilka, Omkar
collection PubMed
description [Image: see text] Ferroptosis is a form of regulated necrosis associated with the iron-dependent accumulation of lipid hydroperoxides that may play a key role in the pathogenesis of degenerative diseases in which lipid peroxidation has been implicated. High-throughput screening efforts have identified ferrostatin-1 (Fer-1) and liproxstatin-1 (Lip-1) as potent inhibitors of ferroptosis − an activity that has been ascribed to their ability to slow the accumulation of lipid hydroperoxides. Herein we demonstrate that this activity likely derives from their reactivity as radical-trapping antioxidants (RTAs) rather than their potency as inhibitors of lipoxygenases. Although inhibited autoxidations of styrene revealed that Fer-1 and Lip-1 react roughly 10-fold more slowly with peroxyl radicals than reactions of α-tocopherol (α-TOH), they were significantly more reactive than α-TOH in phosphatidylcholine lipid bilayers − consistent with the greater potency of Fer-1 and Lip-1 relative to α-TOH as inhibitors of ferroptosis. None of Fer-1, Lip-1, and α-TOH inhibited human 15-lipoxygenase-1 (15-LOX-1) overexpressed in HEK-293 cells when assayed at concentrations where they inhibited ferroptosis. These results stand in stark contrast to those obtained with a known 15-LOX-1 inhibitor (PD146176), which was able to inhibit the enzyme at concentrations where it was effective in inhibiting ferroptosis. Given the likelihood that Fer-1 and Lip-1 subvert ferroptosis by inhibiting lipid peroxidation as RTAs, we evaluated the antiferroptotic potential of 1,8-tetrahydronaphthyridinols (hereafter THNs): rationally designed radical-trapping antioxidants of unparalleled reactivity. We show for the first time that the inherent reactivity of the THNs translates to cell culture, where lipophilic THNs were similarly effective to Fer-1 and Lip-1 at subverting ferroptosis induced by either pharmacological or genetic inhibition of the hydroperoxide-detoxifying enzyme Gpx4 in mouse fibroblasts, and glutamate-induced death of mouse hippocampal cells. These results demonstrate that potent RTAs subvert ferroptosis and suggest that lipid peroxidation (autoxidation) may play a central role in the process.
format Online
Article
Text
id pubmed-5364454
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-53644542017-04-06 On the Mechanism of Cytoprotection by Ferrostatin-1 and Liproxstatin-1 and the Role of Lipid Peroxidation in Ferroptotic Cell Death Zilka, Omkar Shah, Ron Li, Bo Friedmann Angeli, José Pedro Griesser, Markus Conrad, Marcus Pratt, Derek A. ACS Cent Sci [Image: see text] Ferroptosis is a form of regulated necrosis associated with the iron-dependent accumulation of lipid hydroperoxides that may play a key role in the pathogenesis of degenerative diseases in which lipid peroxidation has been implicated. High-throughput screening efforts have identified ferrostatin-1 (Fer-1) and liproxstatin-1 (Lip-1) as potent inhibitors of ferroptosis − an activity that has been ascribed to their ability to slow the accumulation of lipid hydroperoxides. Herein we demonstrate that this activity likely derives from their reactivity as radical-trapping antioxidants (RTAs) rather than their potency as inhibitors of lipoxygenases. Although inhibited autoxidations of styrene revealed that Fer-1 and Lip-1 react roughly 10-fold more slowly with peroxyl radicals than reactions of α-tocopherol (α-TOH), they were significantly more reactive than α-TOH in phosphatidylcholine lipid bilayers − consistent with the greater potency of Fer-1 and Lip-1 relative to α-TOH as inhibitors of ferroptosis. None of Fer-1, Lip-1, and α-TOH inhibited human 15-lipoxygenase-1 (15-LOX-1) overexpressed in HEK-293 cells when assayed at concentrations where they inhibited ferroptosis. These results stand in stark contrast to those obtained with a known 15-LOX-1 inhibitor (PD146176), which was able to inhibit the enzyme at concentrations where it was effective in inhibiting ferroptosis. Given the likelihood that Fer-1 and Lip-1 subvert ferroptosis by inhibiting lipid peroxidation as RTAs, we evaluated the antiferroptotic potential of 1,8-tetrahydronaphthyridinols (hereafter THNs): rationally designed radical-trapping antioxidants of unparalleled reactivity. We show for the first time that the inherent reactivity of the THNs translates to cell culture, where lipophilic THNs were similarly effective to Fer-1 and Lip-1 at subverting ferroptosis induced by either pharmacological or genetic inhibition of the hydroperoxide-detoxifying enzyme Gpx4 in mouse fibroblasts, and glutamate-induced death of mouse hippocampal cells. These results demonstrate that potent RTAs subvert ferroptosis and suggest that lipid peroxidation (autoxidation) may play a central role in the process. American Chemical Society 2017-03-07 2017-03-22 /pmc/articles/PMC5364454/ /pubmed/28386601 http://dx.doi.org/10.1021/acscentsci.7b00028 Text en Copyright © 2017 American Chemical Society This is an open access article published under an ACS AuthorChoice License (http://pubs.acs.org/page/policy/authorchoice_termsofuse.html) , which permits copying and redistribution of the article or any adaptations for non-commercial purposes.
spellingShingle Zilka, Omkar
Shah, Ron
Li, Bo
Friedmann Angeli, José Pedro
Griesser, Markus
Conrad, Marcus
Pratt, Derek A.
On the Mechanism of Cytoprotection by Ferrostatin-1 and Liproxstatin-1 and the Role of Lipid Peroxidation in Ferroptotic Cell Death
title On the Mechanism of Cytoprotection by Ferrostatin-1 and Liproxstatin-1 and the Role of Lipid Peroxidation in Ferroptotic Cell Death
title_full On the Mechanism of Cytoprotection by Ferrostatin-1 and Liproxstatin-1 and the Role of Lipid Peroxidation in Ferroptotic Cell Death
title_fullStr On the Mechanism of Cytoprotection by Ferrostatin-1 and Liproxstatin-1 and the Role of Lipid Peroxidation in Ferroptotic Cell Death
title_full_unstemmed On the Mechanism of Cytoprotection by Ferrostatin-1 and Liproxstatin-1 and the Role of Lipid Peroxidation in Ferroptotic Cell Death
title_short On the Mechanism of Cytoprotection by Ferrostatin-1 and Liproxstatin-1 and the Role of Lipid Peroxidation in Ferroptotic Cell Death
title_sort on the mechanism of cytoprotection by ferrostatin-1 and liproxstatin-1 and the role of lipid peroxidation in ferroptotic cell death
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5364454/
https://www.ncbi.nlm.nih.gov/pubmed/28386601
http://dx.doi.org/10.1021/acscentsci.7b00028
work_keys_str_mv AT zilkaomkar onthemechanismofcytoprotectionbyferrostatin1andliproxstatin1andtheroleoflipidperoxidationinferroptoticcelldeath
AT shahron onthemechanismofcytoprotectionbyferrostatin1andliproxstatin1andtheroleoflipidperoxidationinferroptoticcelldeath
AT libo onthemechanismofcytoprotectionbyferrostatin1andliproxstatin1andtheroleoflipidperoxidationinferroptoticcelldeath
AT friedmannangelijosepedro onthemechanismofcytoprotectionbyferrostatin1andliproxstatin1andtheroleoflipidperoxidationinferroptoticcelldeath
AT griessermarkus onthemechanismofcytoprotectionbyferrostatin1andliproxstatin1andtheroleoflipidperoxidationinferroptoticcelldeath
AT conradmarcus onthemechanismofcytoprotectionbyferrostatin1andliproxstatin1andtheroleoflipidperoxidationinferroptoticcelldeath
AT prattdereka onthemechanismofcytoprotectionbyferrostatin1andliproxstatin1andtheroleoflipidperoxidationinferroptoticcelldeath